The effect of rod domain A148V mutation of neurofilament light chain on filament formation

Journal of Biochemistry and Molecular Biology

Volumn 41, Issue 12, 2008, Pages 868-874

  Lee, In Bum ^a   Kim, Sung Kuk ^a   Chung, Sang Hee ^a   Kim, Ho ^a   Kwon, Taeg Kyu ^b   Min, Do Sik ^c   Chang, Jong Soo ^a  

^a Daejin University   (South Korea)

^b Keimyung University   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

A148V; Charcot marie tooth; Neurofilaments; Self assembly; SW13 cells

Indexed keywords

EID: 58149354850     PISSN: 12258687     EISSN: 02191024     Source Type: Journal    
DOI: 10.5483/bmbrep.2008.41.12.868     Document Type: Article

References (32)

1. Lee, M.K., Xu, Z., Wong, P.C. and Cleveland, D.W. (1993) Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122, 1337-1350.
2. Ching, G.Y. and Liem, R.K. (1993) Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J. Cell Biol. 122, 1323-1335.
3. Nakagawa, T., Chen, J., Zhang, Z., Kanai, Y. and Hirokawa, N. (1995) Two distinct functions of the carboxyl-terminal tail domain of NF-M upon neurofilament assembly: cross-bridge formation and longitudinal elongation of filaments. J. Cell Biol. 129, 411-429.
4. Al-Chalabi, A. and Miller, C.C. (2003) Neurofilaments and neurological disease. Bioessays 25, 346-355.
5. Fuchs, E. and Weber, K. (1994) Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 63, 345-382.
6. Grant, P. and Pant, H.C. (2000) Neurofilament protein synthesis and phosphorylation. J. Neurocytol. 29, 843-872.
7. Pant, H.C. and Veeranna, V. (1995) Neurofilament phosphorylation. Biochem. Cell Biol. 73, 575-592.
8. Nixon, R.A., Paskevich, P.A., Sihag, R.K. and Thayer, C.Y. (1994) Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber. J. Cell Biol. 126, 1031-1046.
9. Betts, J.C., Blackstock, W.P., Ward, M.A. and Anderton, B.H. (1997) Identification of phosphorylation sites on neurofilament proteins by nanoelectrospray mass spectrometry. J. Biol. Chem. 272, 12922-12927.
10. Heins, S., Wong, P.C., Muller, S., Goldie, K., Cleveland, D.W. and Aebi, U. (1993) The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation. J. Cell Biol. 123, 1517-1533.
11. Geisler, N. and Weber, K. (1981) Self-assembly in vitro of the 68,000 molecular weight component of the mammalian neurofilament triplet proteins into intermediate-sized filaments. J. Mol. Biol. 151, 565-571.
12. Wong, P.C. and Cleveland, D.W. (1990) Characterization of dominant and recessive assembly-defective mutations in mouse neurofilament NF-M. J. Cell Biol. 111, 1987-2003.
13. Monteiro, M.J., Hoffman, P.N., Gearhart, J.D. and Cleveland, D.W. (1990) Expression of NF-L in both neuronal and nonneuronal cells of transgenic mice: increased neurofilament density in axons without affecting caliber. J. Cell Biol. 111, 1543-1557.
14. Herrmann, H. and Aebi, U. (2000) Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr. Opin. Cell Biol. 12, 79-90.
15. Lee, M.K. and Cleveland, D.W. (1996) Neuronal intermediate filaments. Annu. Rev. Neurosci. 19, 187-217.
16. Choi, B.O., Lee, M.S., Shin, S.H., Hwang, J.H., Choi, K.G., Kim, W.K., Sunwoo, I.N., Kim, N.K. and Chung, K.W. (2004) Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients. Hum. Mutat. 24, 185-186.
17. De Jonghe, P., Mersivanova, I., Nelis, E., Del Favero, J., Martin, J.J., Van Broeckhoven, C., Evgrafov, O. and Timmerman, V. (2001) Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann. Neurol. 49, 245-249.
18. Fabrizi, G.M., Cavallaro, T., Angiari, C., Bertolasi, L., Cabrini, I., Ferrarini, M. and Rizzuto, N. (2004) Giant ax-on and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurologyo 62, 1429-1431.
19. Georgiou, D.M., Zidar, J., Korosec, M., Middleton, L.T., Kyriakides, T. and Christodoulou, K. (2002) A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics 4, 93-96.
20. Jordanova, A., De Jonghe, P., Boerkoel, C.F., Takashima, H., De Vriendt, E., Ceuterick, C., Martin, J.J., Butler, I.J., Mancias, P. and Papasozomenos, S., et al. (2003) Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 126, 590-597. 28.
21. Mersiyanova, I.V., Perepelov, A.V., Polyakov, A.V., Sitnikov, V.F., Dadali, E.L., Oparin, R.B., Petrin, A.N, and Evgrafov, O.V. (2000) A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet 67, 37-46.
22. Zuchner, S., Vorgerd, M., Sindern, E. and Schroder, J.M. (2004) The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy. Neuromuscul. Disord. 14, 147-157.
23. Gu, L., Troncoso, J.C., Wade, J.B. and Monteiro, M.J. (2004) In vitro assembly properties of mutant and chimeric intermediate filament proteins: insight into the function of sequences in the rod and end domains of IF. Exp. Cell Res. 298, 249-261.
24. Carter, J., Gragerov, A., Konvicka, K., Elder, G., Weinstein, H. and Lazzarini, R.A. (1998) Neurofilament (NF) assembly; divergent characteristics of human and rodent NF-L subunits. J. Biol. Chem. 273, 5101-5108.
25. Sarria, A.J., Nordeen, S.K. and Evans, R.M. (1990) Regulated expression of vimentin cDNA in cells in the presence and absence of a preexisting vimentin filament network. J. Cell Biol. 111, 553-565.
26. Kim, S.K., Cho, S.M., Lee, I.B., Lee, Y.H., Rang, J.H., Choi, J.H., Suh, P.G. and Chang, J.S. (2007) In vitro assay of neurofilament light chain self-assembly using truncated mutants, J. Neurosci. Methods 161, 199-204.
27. Sasaki, T., Gotow, T., Shiozaki, M., Sakaue, F., Saito, T., Julien, J.P., Uchiyama, Y. and Hisanaga, S. (2006) Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants. Hum. Mol. Genet. 15, 943-952.
28. Levy, Y., Hanan, E., Solomon, B. and Becker, O.M. (2001) Helix-coil transition of PrP106-126: molecular dynamic study. Proteins 45, 382-396.
29. Prusiner, S.B., Scott, M.R., DeArmond, S.J. and Cohen, F.E. (1998) Prion protein biology. Cell 93, 337-348.
30. Inouye, H. and Kirschner, D.A. (1998) Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction, J. Struct. Biol. 122, 247-255.
31. Kim, N.H. and Kang, J.H, (2003) Oxidative modification of neurofilament-L by copper-catalyzed reaction. J. Biochem. Mol. Biol. 36, 488-492.
32. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J. and Klenk, D.C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.